Chimin Health Management Co., Ltd.
603222.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.36B
Close$
$-2.97
136.1% downside
Current Fair Value
136.1% downsideOvervalued by 136.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.36 Billion |
|---|---|
| Enterprise Value | $4.74 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 0.37 |
| Outstanding Shares | 470,033,040 |
Return
| Return on Equity | -22.27% |
|---|---|
| Return on Assets | -10.96% |
| Return on Invested Capital | -12.62% |
Valuation & Multiples
| P/E Ratio | -17.74 |
|---|---|
| PEG | 44.54 |
| Price to Sales | 8.21 |
| Price to Book Ratio | 4.11 |
| Enterprise Value to Revenue | 7.22 |
| Enterprise Value to EBIT | -25.17 |
| Enterprise Value to Net Income | -20 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.72 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Chimin Health Management Co., Ltd.
1,890 employees
CEO: Yunfei Tian Chimin Health Management Co., Ltd., formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd., is a Chinese enterprise specializing in the research, production, and distribution of pharmaceuticals for human use and medical apparatus. Its...